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Chemoreflexes after Intravenous Injection of Dextran
Sulf ate in the Rabbit
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Richard J. Ulevitch
From the Departments of Internal Medicine and Pathology, University of Michigan Medical School, Ann Arbor, Michigan, and
Department of Immunopathology, Research Institute of Scripps Clinic, La folia, California
SUMMARY. The hypotension and bradycardia observed after intravenous injection of dextran
sulf ate in rabbits was prevented by prior depletion of circulating platelets, but was not prevented
by depletion of the third component of complement or Hageman factor. Dextran sulfate injection
caused immediate thrombocytopenia with temporary localization of platelets within lungs. Mor-
phological analysis revealed platelet aggregates in lung capillaries. The platelets had changed
shape and were in the process of degranulating. Serotonin and histamine levels in blood increased
approximately 5-fold and 7-fold, respectively,.after dextran sulfate injection. The cardiovascular
events following dextran sulfate injection were mimicked by intravenous serotonin but not by
intravenous histamine injection, although a combination of serotonin and histamine reproduced
the pattern of blood pressure changes better than did either agent alone. Quantification of platelets
trapped in lung revealed that the potential release of serotonin from trapped platelets could
account for the rise in plasma serotonin concentration and the hemodynamic changes observed.
Both the dextran sulfate-induced cardiovascular effects and serotonin-induced hypotension were
markedly diminished by cutting vagus and depressor nerves, and were virtually abolished by
carotid ligation in addition to nerve section. These results support the concept that platelet
activation within rabbit lungs may cause hypotension via serotonin-induced chemoreflexes. (Circ
Res 57: 262-277, 1985)
ACUTE hypotension follows intravenous injections
of numerous substances. This abrupt decrease in
blood pressure may be mediated by direct effects of
drugs on resistance vessels. On the other hand,
similar events may be initiated by specific antigen
recognition leading to activation of mast cells and
basophils (anaphylaxis), or they may be induced by
non-allergic reactions such as are seen after injection
of contrast media (anaphylactoid). The precise chain
of events responsible for acute hypotension in the
latter situation is not fully understood, although
histamine is thought to be an important mediator.
In the rabbit model of IgE-anaphylaxis, acute hy-
potension has been shown to be platelet-dependent
(Benveniste et al., 1972; Pinckard et al, 1977) and
secondary to release of platelet-activating factor
from basophils (McManus et al., 1979). In this study
(also in the rabbit), the contributions of different
mediator systems activated after intravenous injec-
tion of an anionic heparin-like polymer, dextran
sulfate, have been analyzed. The results of this study
show that a powerful chemoreflex mediated by
platelet serotonin was responsible for causing the
acute hypotension. A similar sequence of events
could contribute to the anaphylactoid response, in-
cluding acute hypotension, sometimes seen in hu-
mans immediately after injection of various sub-
stances, or after the hookup of extracorporeal cir-
culation systems.
Methods
Male New Zealand white rabbits weighing 2-3 kg were
used. They were fasted for 24-48 hours before study,
although they had free access to water. Arterial pressure
measurements were made directly with catheters inserted
under local anesthetic into the femoral artery (Intramedic
PE50). Infusions and venous pressure measurements were
made via a catheter inserted into the femoral vein (In-
tramedic PE50). Both catheters were introduced to the
approximate level of the diaphragm. For infusion into the
right ventricle, the venous catheter was advanced until
pressure recordings showed appropriate right ventricular
pressure changes. In each case, the position of the catheter
subsequently was checked by autopsy at the end of the
study. Catheters sometimes were inserted the day prior to
study. In this case, the catheters were filled with saline,
knotted, and buried under the skin, with the skin closed
by suture. The following day, access to catheters was
obtained by cutting the sutures. For measurements of
arterial pressure, rabbits were placed supine on boards
and were secured by cords to the limbs. Since the response
to dextran sulfate was not affected by barbiturate anes-
thesia, many of the studies described were performed
under a barbiturate general anesthetic (sodium pentobar-
bitone, 10-15 mg/kg) administered as required via a cath-
eter in the marginal ear vein). Arterial and venous pressure
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was measured with a Statham pressure transducer (P37B)
and a Statham SP1400 blood pressure monitor. For most
studies, the data were expressed as the mean arterial
pressure, which was either recorded directly from the
monitor or was calculated (diastolic plus one-third of the
difference between systolic and diastolic pressure) from
the printout that had been calibrated previously.
Depletion of C3 in Rabbits using Cobra Factor
Cobra factor was purified from crude lyophilized
venom from Naja naja as previously described (Ulevitch
and Cochrane, 1977). Purified cobra factor (250 U) was
injected intraperitoneally into three rabbits on two occa-
sions (3 days and 2 days before study) as previously
described (Ulevitch and Cochrane, 1977). Blood taken on
the day of study showed C3 levels, as measured by radial
immunodiffusion, to be less than 4% of the levels prior to
cobra factor treatment in all animals.
Depletion of Hageman Factor with Goat Antirabbit
HFIgG
Hageman factor (HF) was purified from rabbit plasma
by a method similar to that described for human HF
(Griffin and Cochrane, 1976). Goats were immunized with
purified HF in complete Freund's adjuvant every 2-3
weeks for 6 months. The serum collected showed a single
precipitation band against purified rabbit HF and rabbit
plasma by immunodiffusion analysis. Purification of the
IgG was performed as previously described (Wiggins et
al., 1979). Rabbits were depleted of circulating HF by an
initial intravenous injection of goat antiHF IgG (240 mg)
followed by infusion of the IgG at 32 mg/hr, intrave-
nously, for the duration of the experiment. After the initial
injection, the rabbit shivered for 2-3 minutes, and, there-
after, had no obvious ill effects from the infusion. No
effect of antiHF IgG infusion on circulating levels of Factor
XI, prekallikrein, high molecular weight kininogen, or
Factor IX was observed. The C3 level fell to approximately
60% of normal within 1 hour of infusion of goat antirabbit
HF. This fall in C3 subsequently was shown to be due to
aggregates of IgG in the goat antiHF preparation. For
these studies, proteins were measured by the following
methods: prekallikrein and C3 by radial immunodiffusion.
HF, Factor XI and high molecular weight kininogen were
measured as procoagulant activity using human HF, Factor
XI, and high molecular weight kininogen-deficient plas-
mas in a kaolin-activated partial thromboplastin time as-
say (Bouma and Griffin, 1977). Depletion of HF to less
than 0.1 % of control levels for up to 8 hours was achieved.
"Cr-Labeling of Platelets
Rabbit platelet-rich plasma from 200 ml of citrated
rabbit blood was incubated with MCr (500 jiCi) for 30
minutes at 37°C. The platelets then were washed twice
by centrifugation in platelet-poor citrated plasma. MCr
platelets (0.5-1.2 /iCi) were then injected into each of six
rabbits 18 hours prior to study.
Platelet Depletion
Sheep antirabbit platelet antiserum, which was kindly
supplied by Dr. C. Cochrane, Department of Immuno-
pathology, Research Institute of Scripps Clinic, was used
to deplete rabbits of circulating platelets. Preliminary stud-
ies snowed that intraperitoneal injection of 5 ml of anti-
serum resulted in a decrease in circulating platelet levels
to less than 10% of the starting level within 1 hour, and
that this extent of platelet depletion lasted for at least 5
hours. Furthermore, in association with the depletion of
platelets, there were no significant changes in circulating
neutrophil leukocytes or monocytes in the pilot study.
For the platelet-depletion studies described, three rab-
bits were depleted by intraperitoneal injection of 5 ml of
sheep antirabbit platelet antiserum. Three hours after ad-
ministration of the antiserum, the platelet count had fallen
to 3.2, 9.8, and 4.8% of initial values. Three control rabbits
that received non-immune serum had platelet counts of
89.4, 109.4, and 110.1% of initial values. Counts for
mononuclear cells were 66.7, 97.6, and 75.6% in the
platelet-depleted animals compared with 97.0, 76.7, and
160% in the control animals 3 hours after antiserum
injection. Neutrophil counts were 79.3, 83.5, and 72.3%
in platelet-depleted rabbits compared with 75.4, 120.0,
and 268% in control animals. The third control rabbit had
a marked increase in both blood mononuclear and neutro-
phil levels in the 3-hour period after non-immune serum
injection. Otherwise, values obtained with the control
animals were comparable to those of the experimental
rabbits. Dextran sulfate (20 mg/kg intravenously) was
administered to both groups of animals 3 hours after they
had received either antiplatelet antiserum or non-immune
globulin.
Platelet Distribution Study
MCr-Labeled platelets (0.9 /xCi) were injected into each
of six rabbits 18 hours before study. Duxtran sulfate
(DxSO,, 20 mg/kg in 0.15 M NaCl) was injected into three
rabbits, while three rabbits received 0.15 M NaCl alone.
One minute after DxSO4 (or saline) injection, each rabbit
received 12SI-albumin (1 /iCi) injected in 5 ml 0.15 M NaCl
into the inferior vena cava via a femoral vein catheter.
After another minute, rabbits were killed by intravenous
injection of sodium pentobarbitone (120 mg). Blood was
taken before injection of DxSO4 for counting MCr and
platelets. After sacrifice, tissues (lungs, heart, liver, spleen,
kidneys, fat, muscle, skin, stomach, and intestine) were
removed, weighed, and counted for radioactivity. With
the ratio of MCr to 123I in the blood and the amount of 12JI
in each organ known, it was possible to calculate the
expected "Cr in each organ based on that organ's blood
content. This calculated value was subtracted from the
observed value and corrected for organ weight to give the
value in Table 1. The high levels in liver and spleen
represent platelet destruction in the 18 hours between
"Cr-platelet injection and death of the animal, and are
similar in the DxSO4-treated and control animals. The
major^  difference between the groups of animals was in
the lung. Since the blood platelet counts before injection
of DxSO4 were known, and corresponded to a Cr count
in the blood, it was possible to calculate the excess number
of platelets per gram of lung present in the DxSO4-treated
animals. As the total lung weights for each animal were
also measured, it was possible to estimate the total number
of platelets trapped in the lung 2 minutes after DxSO4
injection.
Morphological Studies
Lung samples for transmission electron microscopic
(TEM) and light microscopic (LM) evaluation were ob-
tained from six New Zealand white rabbits. Rabbits were
killed 2, 3, 20, and 30 minutes after DxSO4 injection. Two
rabbits were used as controls. For control and 2- or 3-
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minute studies rabbits were anesthetized with sodium
pentobarbitone, then given either normal saline (control)
or DxSO4 (20 mg/kg) intravenously. For the 20- and 30-
minute studies DxSO4 was injected prior to anesthesia.
Rabbits were killed by sodium pentobarbital injection (170
mg) given intravenously over 30 seconds. The thoracic
cavity was immediately exposed. The trachea was canu-
lated, and the lung was inflated in situ with approximately
50 ml of cold 4% glutaraldehyde buffered with 0.1 M
cacodylate, pH 7.3, (300 mOsm/liter). The entire lung was
excised and placed in cold 4% buffered glutaraldehyde.
Fifteen minutes later random sections (1 mm3) were cut
for TEM evaluation, and adjoining tissue was taken for
LM histology. The lung pieces for TEM were fixed over-
night at 4°C in the buffered glutaraldehyde, then rinsed
well with 0.1 M cacodylate buffer The samples were
postfixed in 2% OsO, (buffered with 0.1 M cacodylate, pH
7.3) for 1 hr at 4°C, dehydrated in graded alcohols to
propylene oxide, infiltrated with epon/araldite:propylene
oxide mixture, embedded in epon/araldite resin, and po-
lymerized overnight at 65°C. Ultra-thin sections were cut,
stained with 2% uranyl acetate and lead citrate, and
examined on a Philips 201 transmission electron micro-
scope.
Plasma Serotonin Measurement
Blood (1.8 ml) was drawn from a femoral arterial cath-
eter and immediately added to 200 ul of acid-citrate-
dextrose anticoagulant. After being gently mixed, 1 ml of
blood was added to 200 fi\ of EDTA (4 mg/ml) in a
polypropylene conical centrifuge tube and centrifuged on
a Beckman microfuge (Beckman Instruments, Inc.). Plasma
was removed and stored frozen at —30°C. Measurement
of serotonin was performed by the method described by
Parbtani and Cameron (1979). This method involves the
formation of a fluorophore by serotonin and O-phthaldi-
aldehyde (OPT) under acid conditions. Fluorescence emit-
ted at 475 nM while exciting at 360 nM was measured on
an SF 330 spectrofluorometer (Varian Instruments). This
method assumes that the major substance in plasma which
will fluoresce under these conditions is serotonin. In con-
trol studies, DxSO4 and histamine did not induce fluores-
cence, and the spectra for serotonin and plasma were
similar, indicating that serotonin was the major substance
giving rise to fluorescence under the conditions of study.
The recovery of serotonin added back to platelet poor
TABLE 1
nCr-Platelet Accumulation in Various Organs 1 Minute after
Injection of DxSO4 or Saline (control)
Lung
Heart
Liver
Spleen
Kidney
Skin
Muscle
Fat
Stomach
Intestine
"Cr in excess of blood contribution
(counts/min per g tissue) (n = 3)
Control
1,307 ± 351
476 ± 109
2,438 ± 594
43,058 ± 10,643
85 ±45
320 ± 163
93 ±62
15 ± 8
86 ±54
25 ±21
Dextran sulfate
5,572 ± 863*
223 ± 124
2,244 ± 943
36,562 ± 9,850
144 ± 73
475 ± 235
27 ± 10
11 ± 4
34 ± 18
50 ±38
Results are expressed as mean ± SEM.
•P<0.05.
Circulation Research/Vol. 57, No. 2, August 1985
plasma was 71%. The limit of sensitivity of the assay was
10 ng/ml (n = 10). The coefficient of variation was 19%
(standard deviation X 100 divided by the mean for 10
measurements).
To confirm that serotonin was present in plasma, we
also, performed high pressure liquid chromatographic
(HPLC) analyses of plasma. These analyses were per-
formed on plasma samples from which the protein had
been precipitated with trichloroacetic acid. Twenty micro-
liters of trichloroacetic acid (200 g/100 ml) were added to
200 n\ of plasma and allowed to stand in ice for 30
minutes. The sample was centrifuged, and the supernatant
was washed with 500 til of diethyl ether. One hundred
microliters of sample were applied to a 30 cm X 4 mm
MCH 10 reverse phase column (Varian Instruments) and
run on an LC 5000 liquid chromatograph (Varian Instru-
ments). The effluent was monitored at 210 run with a
variable wavelength UV 50 detector (Varian Instruments).
The buffer consisted of 12% acetonitrile containing 0.1%
trifluoroacetic acid throughout. The retention time for
serotonin was 9.5 minutes.
Plasma Histamine Measurement
Blood was drawn into anti-coagulant, centrifuged, sep-
arated as described for serotonin, and then stored at
-70°C for assay. A specific histamine assay using [3H]-S-
adenosyl methionine to methylate histamine in the pres-
ence of histamine N-methyltransferase, as described by
Dyer et al. (1982), was used. Briefly, the isotope, enzyme,
and sample were incubated at 37°C for 1.5 hours. The
reaction was stopped by the addition of perchloric acid.
After centrifugation, the supernatant was extracted with
chloroform. The extracted material was dried under nitro-
gen," then reconstituted in chloroform and spiked with
unlabeled methyl histamine. This mixture was spotted
onto thin layer plates and run in a 95:10 (vol/vol) ace-
tone:ammonium hydroxide system. The plates then were
dried in an oven, sprayed with O-phthaldialdehyde, re-
dried, and the spots were visualized by ultraviolet light.
The spots were scraped off into a scintillation vial, ex-
tracted with 0.1 N HC1, and, after addition of sdntillant,
were counted on a /S-counter. All samples were done in
duplicate and were compared to a standard curve con-
structed by adding known amounts of histamine to di-
alyzed rabbit plasma. The coefficient of variation of the
assay was 32%, and the limit of sensitivity was 200 pg/
ml.
Nerve Section and Carotid Ligation
In more than 20 rabbits studied in which femoral artery
catheters had been placed under local anesthetic (2%
lidocaine), and in more than 30 rabbits that received
sodium pentobarbitone anesthesia, we noted no difference
in cardiovascular response to serotonin, histamine, or
DxSO4 injection. Therefore, to minimize discomfort to
animals, we studied the rabbits under sodium pentobar-
bitone general anesthesia (10-15 mg/kg, intravenously, as
required). Femoral arterial and venous catheters were
placed in each rabbit to approximately the level of the
diaphragm. A midline incision was made in the skin from
the jaw to the manubrium, and the pretracheal fascia was
split in the midline. Muscles lying in front of the trachea
were cut, and a tracheal cannula (5-cm portion of a 2-ml
plastic pipette) was secured with a silk thread. A longitu-
dinal incision through the strap muscles was made 0.5 cm
from the midline according to the method of Kremer et al.
(1933). The carotid artery, vagus, and depressor nerves
weTe identified and isolated by gentle blunt dissection.
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For the study described (Figs. 12 and 13), both vagus
and depressor nerves were cut on both sides in three
rabbits. In the control animals, the nerves were identified
and isolated but were not cut (sham-operated). After nerve
section, there was an increase in mean arterial pressure of
approximately 5-15%, and respiration became slower and
deeper. A 30-minute interval was allowed between nerve
section and DxSO4 injections. At the end of this time, the
mean arterial pressure was still approximately 5-15%
above pre-section levels. In one rabbit, the response to
bradykinin was measured before and after nerve section.
The change in mean arterial pressure to 40, 200, and 1000
ng bradykinin were 0, 7, and 19 mm Hg before section
and 0, 15, and 40 mm Hg after nerve section. Thus, the
response to bradykinin remained intact after nerve section.
In the experiment in which both internal carotid arteries
were tied (Figs. 14 and 15), the rabbits first were treated
by nerve section, as described above. Clamping of one or
both internal carotid arteries produced an immediate in-
crease in mean arterial pressure of about 30%. If we
allowed an interval of 60 minutes, mean arterial pressure
fell to approximately 10% above the initial levels. For the
experiment described in Figures 14 and 15, 60-minutes
elapsed between carotid ligation and rechallenge with
serotonin and the DxSO* injection.
For the nitroprusside/bradykinin study (Fig. 19), fem-
oral arterial catheters were placed in the rabbits, under
barbiturate anesthetic. The drugs to be tested (serotonin
22 ng, bradykinin 1 fig, or sodium nitroprusside 50 /jg)
were injected as a bolus into an ear vein in 0.5 ml of
0.15 M NaG. Each drug was tested in duplicate at each
stage of the experiment in four rabbits. After the control
studies, the depressor and vagus nerves were in turn
identified and cut as described above. After 10 minutes,
the drugs were tested. Both carotid arteries then were tied.
After 15 minutes, the drugs were tested again.
Statistical Analysis
Paired f-test was used for this analysis.
Miscellaneous
Human deficient plasmas were purchased from George
King Biomedical, Inc. Angiotensin-converting enzyme in-
hibitor (SQ 20881) was kindly provided by Dr. W.B.
McDowell, of the Squibb Institute of Medical Research.
Dextran sulfate (mol wt 500,000) was purchased from
Pharmacia, Fine Chemicals, and was dissolved in sterile
0.15 M NaCl; serotonin creatine sulfate, histamine dihy-
drochloride, and bradykinin were purchased from Sigma
Chemical Co.; chromium-51 was purchased from New
England Nuclear; cobra venom was purchased from Bio-
logicals Unlimited, Inc.; and cimetidine (Tagamet) came
from Smith, Kline and French Laboratories. Methysergide
maleate was kindly provided by Ms. K.D. Roskaz, Sandoz
Inc. Ketanserin tartrate (kindly provided by Dr. Clinton
Webb, Department of Physiology, University of Michigan)
came from Janssen Pharmaceutica (Janssen R & D Inc.)
and sodium nitroprusside was from Abbott Laboratories.
Results
Pathophysiological Consequences of Dextran
Sulfate Injection
Dextran sulfate (mol wt 500,000) injection (20
mg/kg/ intravenously, given over a 20-second pe-
riod) had no immediate adverse effect on the rabbit.
After a 45- to 60-second interval, there was a slight
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rise in systemic arterial pressure, followed immedi-
ately by a profound decrease in arterial pressure of
about 30-40% accompanied by bradycardia (Fig. 1).
This hypotension was associated with transient ir-
regular respiration and, in some rabbits, mild wheez-
ing, defecation, or micturition. Large waves of per-
istaltic bowel movements were visible through the
abdominal wall. These changes lasted approxi-
mately 1 minute. Over the next 5-15 minutes, the
arterial pressure returned toward the preinjection
values, but never attained those values, remaining
at 90-95%. There were no apparent aftereffects,
with the exception of a severe tendency to bleed. At
lower doses of injected DxSO*, some rabbits became
hypotensive and some did not. The response tended
to be all-or-nothing. Increasing the amount of
DxSO4 injected did not increase the hypotension.
Blood Cell Changes following DxSO4 Injection
Platelets
In three separate experiments, intravenous injec-
tion of DxSO* (20 mg/kg) was immediately followed
by disappearance of between 50 and 90% of the
platelets from blood within 5 minutes of DxSO4
injection. By 60 minutes, platelet counts were re-
turning toward preinjection levels. This is illustrated
in Figure 2, in which 51Cr platelets were used in a
group of three rabbits. Of note is the fact that the
level of 51Cr platelets at 4 hours is approximately
the same as the level that would be predicted from
the slope of disappearance of 51Cr if no DxSO* had
been injected. Similar results were found when
platelets were counted directly in other experiments
(data not shown). This implies that platelets were
sequestered somewhere in the animal following
DxSO4 injection, but that they returned to the cir-
culation and were not removed and destroyed by
D1SO4
0 3 4 s s n
MINUTES
FIGURE 1. Representative cardiovascular changes following
injection (20 mg/kg) in a rabbit. There is an initial lag period of 30-
45 seconds followed by bradycardia, hypotension, and a rise in the
central venous pressure (CVP). By 2 minutes, a tachycardia super-
venes, accompanied by a fall in CVP. The arterial pressure gradually
rises toward normal over a 15- to 20-minute period.
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FIGURE 2. Comparison of changes in blood platelets ("Cr platelets)
and neutrophils and monocytes (counted in a counting chamber) from
controls and from rabbits that had been injected with DxSOt (20 mg/
kg) which had been depleted of C3 with cobra factor (CoF) (n = 3
rabbits in each group). During the hour preceding DxSOt injection,
there was a 4-5% fall in circulating "Cr platelets. The responses
were not statistically significantly different (P = 0.13 at 5 minutes)
except at the 4-hour point (P = 0.03). Both groups of animals showed
an immediate unequivocal decrease in blood platelets following
DxSOt injection. By 4 hours after DxSO{ injection, the "Cr platelets
had returned to the circulation at approximately the predicted level,
indicating that extensive platelet lysis had not occurred. The blood
neutrophil count fell to 40% of control following DxSOt injection,
but by 1 hour after DxSOt injection had rebounded to 340% of initial
values. These changes were prevented by cobra factor treatment (P <
0.05 at both 5 minutes and 1 hour; P > 0.05 at 4 hours), indicating
that C3 was necessary for the changes in blood neutrophil count. The
apparent fall in blood monocyte count to 46% of control at 5 minutes
was prevented by prior treatment with cobra factor. None of the
differences were statistically significant.
the spleen. In other words, the thrombocytopenia
was not due to thrombolysis.
In a parallel experiment in which three rabbits
were depleted of C3 by prior injection of cobra factor
(see Methods), DxSO4 injection induced a fall of 51Cr
platelets which was not statistically significantly dif-
ferent from that seen in the control rabbits over the
first hour (Fig. 2). These results suggest that the
thrombocytopenia was not completely C3 -depend-
ent, although complement activation may have con-
tributed to thrombocytopenia.
Neutrophils
Within 5 minutes of DxSO4 injection, there was a
fall in neutrophil count to 36% of the starting values
(Fig. 2). This was followed by a neutrophilia of 340%
by 60 minutes which persisted until 4 hours after
DxSO4 injection (Fig. 2). These changes in neutrophil
count were prevented by prior depletion of C3 by
cobra factor injection (Fig. 2). These data suggest
that complement activation occurred following
DxSO4 injection and was responsible for the initial
neutropenia followed by a rebound neutrophilia.
Circulation Reseaich/VoZ. 57, No. 2, August 1985
Mononudear Cells
The mononuclear cell count (monocytes and lym-
phocytes) fell by 46% 5 minutes after DxSO4 injec-
tion. This fall was also prevented by prior cobra
factor treatment (Fig. 2).
Basophils
Basophils were counted using a metachromatic
stain (Meng et al., 1973). Two minutes after DxSO4
injection, the metachromatically stained cells in
blood had fallen to 18% of initial levels. By 30
minutes, the level had increased to 84% of starting
values (data not shown).
Hematocrit
There was a small rise in hematocrit of 2-3% 5
minutes after DxSO4 injection (data not shown).
Effect of Depletion of C3 upon DxSO4-Induced
Hypotension
DxSO4 is known to activate complement. There-
fore, to determine whether the complement system
was playing a major role in the hemodynamic
changes seen after DxSO4 injection, three rabbits
were depleted of C3 with cobra factor to less than
4% of control levels (see Methods and Fig. 2). After
DxSO4 injection, both cobra factor-treated and con-
trol rabbits exhibited brisk hypotensive responses
which were not significantly different (Fig. 3). There
was therefore no evidence that C3 was essential to
mediation of the cardiovascular response to DxSO4.
Effect of Depletion of Hageman Factor with Goat
Anti-H* IgG
DxS04 is known to activate the HF system, and
activation of HF in plasma by DxSO4 leads to bra-
dykinin generation (Kluft, 1978). Since bradykinin
injection in the rabbit can cause bradycardia and
hypotension similar to that seen after DxSO4 admin-
istration, studies were performed to examine the
possibility that HF-mediated bradykinin formation
was responsible for the observed cardiovascular
changes. The rabbits were depleted of HF to less
than 0.1% of initial circulating HF level by infusion
of goat anti HF IgG (see Methods). After DxSO4
injection, there was a brisk hypotensive response in
both rabbits associated with bradycardia similar to
that seen in a rabbit receiving control non-immune
IgG (Fig. 4). This implies that the HF was not essen-
tial for the cardiovascular response to DxSO4 injec-
tion.
Effect of Inhibition of Angiotensin-Converting
Enzyme on DxSCVInduced Hypotension
To investigate further whether bradykinin gener-
ated by a different mechanism could be mediating
cardiovascular events following DxSO4 injection, the
effect of prevention of bradykinin destruction by
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FIGURE 3. Changes in mean arterial pressure (MAP) following DxSOt
injection (20 mg/kg) in rabbits depleted of C3 with cobra factor (n =
3) and in control animals (n •= 3). After DxSOt injection, there was
an initial rise in MAP followed by a fall to approximately 70 and
80% in both the control and cobra factor-treated animals, respectively.
These differences were not significantly different. The cardiovascular
changes m response to DxSOt were therefore not prevented by prior
depletion of C3.
inhibition of kininase II (the angjotensin-coverting
enzyme) was studied. SQ 20881 (5 mg/kg) was
injected into three rabbits 10 minutes before DxSO4
injection, (hi parallel studies, this dose of SQ 20881
potentiated bradykinin-induced hypotension more
than 10-fold.) The results are shown in Figure 5. SQ
20881 actually inhibited the DxSO4-induced hypo-
tension and bradycardia. The reason for this is not
known. However, the result is the opposite of that
which would be expected if bradykinin were a me-
diator of the DxSO4-induced cardiovascular effects.
These data make it very unlikely that kinin genera-
tion was contributing to DxSO4-induced hypoten-
sion and bradycardia in these experiments.
HAGEMAN FACTOR DEPLETED
1
 D x S 0
FIGURE 4. Arterial pressure recordings from a Hageman factor (HF)-
depleted rabbit (see Methods) and a control rabbit. In both cases, the
hypotension and bradycardia began approximately 45 seconds after
DxSOt injection. These findings show that HF was not required for
the initial fall in MAP.
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FIGURE 5. Comparison of arterial pressure changes in control animals
and in rabbits treated with angiotensin<onverting enzyme inhibitor
(SQ 20881) (n = 3 for both groups). The SQ 20881 prevented rather
than enhanced the initial fall in MAP seen following DxSOt injection.
Effect of Depletion of Blood Platelets
Depletion of blood platelets to less than 10% of
normal with antiplatelet serum (see Methods) pre-
vented the hypotension and bradycardia in response
to DxSO4 injection (Fig. 6). These data imply that
platelets play an essential role in mediating the
response.
Distribution of Blood Platelets after DxSO«
Injection
51Cr-Labeled platelets were used to determine
what had happened to the platelets which had
disappeared from the blood. Rabbits were injected
with a blood marker (125I-albumin) 1 minute after
DxSO4 injection and were killed 1 minute later. From
the ratio of 12SI-albumin to 51Cr platelets in the blood
and organs, it was possible to calculate the MCr
present in each organ contributed by blood alone
(see Methods). This calculated amount of 51Cr was
subtracted from the measured slCr in each organ to
give the values in Table 1. The principal difference
between the control and DxSO4-treated animals was
the excess 51Cr in the lung 2 minutes after DxSO4
injection. The high levels of 51Cr in the spleen and
liver in both control and DxSO4 animals reflect
,DiSO.
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FIGURE 6. The effect of platelet depletion (see Methods) on the
cardiovascular response to DxSOt injection (n = 3 for both groups).
Depletion of platelets prevented the initial fall in MAP.
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platelet breakdown in the 18 hours during which
Cr-platelets were circulating prior to study.
Quantification of Platelets in the Lung
2 Minutes after DxSO« Injection
The actual number of platelets trapped in the lung
after DxSO4 injection was calculated from (1) the
mean difference in 51Cr counts between experimen-
tal and control rabbits (4265 counts/min 51Cr/mg
lung tissue), (2) the mean total lung weight (11.0 g),
and (3) the mean blood platelet count and corre-
sponding 51Cr level before DxSO4 injection (3.8 X
108 platelets/ml = 2558 counts/min felCr/ml). Ap-
proximately 7.0 X 109 more platelets were estimated
to be in the DxSO4-treated rabbit lungs than in
control rabbit lungs. This number corresponds to
only 11% of the total number of circulating platelets.
Since 50-90% of the platelets disappeared from the
circulation after DxSO4 injection in three separate
experiments and the lung seemed to be the only site
of platelet accumulation after DxSO4 injection, this
leaves a large number of platelets unaccounted for.
This could be explained by platelet lysis, but such
an explanation does not seem likely in view of the
data shown in Figure 2, where the level of Cr
platelets 4 hours after DxSO4 injection was close to
the predicted value. In other words, there was no
evidence for net permanent loss of platelets. An
alternative explanation is that increased lung perme-
ability occurs after DxSO4 injection. The fact that
increased permeability did occur was shown by
finding increased I-albumin in lungs (6387 ± 1856
counts/min per g in DxSO4-treated group compared
with 1418 ± 423 counts/min per g in control group,
P < 0.05) in addition to intraalveolar hemorrhage
immediately after DxSO4 injection (Fig. 7). If *I-
albumin was leaking out of the vascular compart-
ment into the lungs after DxSO1254 injection, then the
use of I-albumin as a blood marker would result
in falsely low calculated values for platelet trapping
in the lung. The calculation that 7 X 10 platelets
Circulation Research/Vol. 57, No. 2, August 1985
were trapped in the lung therefore is probably an
underestimate.
Ultrastructural Analysis of Lungs after DxSO4
Injection
Lung tissue was examined ultrastructurally from
a control rabbit and rabbits sacrificed 2, 3, and 30
minutes after DxSO4 injection (see Methods).
In normal rabbit lung (Fig. 7A), platelets were
rarely seen, and, when present, were rod-shaped
and contained numerous dense granules. Only an
occasional neutrophil was seen.
Within 2 or 3 minutes of DxSO4 injection, many
changes had occurred (Fig. 7, B and C): The lumina
of some capillaries were filled with granular amor-
phous material which was probably DxSO4 or a
plasma-DxSO4 mixture. Within this amorphous ma-
terial were many platelets which were irregularly
shaped, contained vacuolar structures, and had
fewer dense granules than control platelets. Higher
magnification revealed what appeared to be gran-
ules in the process of passing into vacuolar structures
that were in direct communication with the exterior
of the cell (Fig. 8). In addition to the platelet changes,
other types of cells had appeared in the lung (Fig.
7, B and C). These were (1) numerous neutrophils
that were present both in capillaries which did and
which did not contain amorphous material, (2) nu-
merous eosinophils, and (3) cells with multilobed
nuclei whose cytoplasm contained patchy dense
granule-like material. These cells often appeared to
lie beside eosinophils (Fig. 7, B and C) within lung
capillaries, and are probably degranulated basophils.
Erythrocytes were present in alveolar spaces (Fig.
7C).
Thirty minutes after DxSO4 injection (Fig. 7D),
most of the changes noted at 2 and 3 minutes had
disappeared. No erythrocytes were seen in alveolae,
and no amorphous material was present in capillar-
ies. Neutrophils still were present, but the eosino-
phils and basophils had disappeared. Many more
FIGURE 7. Ultrastructural analysis of rabbit lung
removed before (panel A), 2-3 minutes after (panels
B and Q, and 30 minutes after (panel D) DxSOt
injection. In panel A a few rod-shaped platelets (P)
containing dense granules are seen, with only an
occasional intravascular neutrophil (N) and intra-
alveolar macrophage (M). Immediately after DxSOt
injection (panels B and Q, capillaries are filled with
amorphous material (D) which is probably D1SO4.
There are numerous irregularly shaped platelets (P)
within the amorphous material. There are also
numerous neutrophils (N), eosinophils (E), and cells
which may be degranulated basophils (B). In addi-
tion, red cells (R) have extravasated into the alveo-
lar space. By 30 minutes after DxSO4 injection
(panel D), the platelets have not yet returned to
their original shape and are still plentiful in the
lung capillaries, but otherwise the lung architecture
appears normal. 120GX.
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FIGURE 8. Ultrastructural analysis of a single capillary containing
granular amorphous material D (probably DxSOJ. Two platelets are
seen. The upper platelet contains a large vacuolar structure (V) and
a dense granule (DC) which appears to be in the process of fusing
with a smaller vacuole. The lower platelet appears to be attached to
endothelium (E) by spike-like projections. A dense granule (DG)
appears to be in the process of dissolving within a vacuole which is
in continuity with the outside of the cell ('open canalicular system,
OCS). 11,250*.
platelets were present than in normal lung. Some
were large (up to half the diameter of an erythro-
cyte). They were rounded, contained many vacuole-
Uke structures, and few or no dense granules.
These observations are compatible with the con-
cept that DxSO4 accumulates in lung capillaries after
intravenous injection and remains there for at least
3 minutes. Platelets became trapped and activated
in these capillaries. Dense granular contents were
released from platelets via an open canalicular sys-
tem, as has previously been described (White, 1974).
Other circulating cells (neutrophils, eosinophils, and
probably also basophils) accumulate in the lung
capillaries. There was a leak of erythrocytes out of
capillaries into alveolar space. By 30 minutes after
DxSO4 injection, the lung anatomy was returning
toward normal with platelets still showing signs of
having been activated.
Amount of Histamine and Serotonin Released
from Platelets in Lung
Dense granules from rabbit platelets contain his-
tamine and serotonin. The amounts of serotonin and
histamine present in rabbit platelets have been
measured previously [serotonin 38.5, and histamine
26.2 nmol/mg protein, respectively (Da Prada et al.,
1981)]. With this information, and knowing the
number of platelets trapped in the lung 2 minutes
after DxSO4 injection from data described above (7
X 109 platelets), and the number of rabbit platelets
constituting 1 mg platelet protein [2.2 X 10" plate-
lets/mg protein (personal observation)], it was pos-
sible to estimate that approximately 100 jig hista-
mine and 217 /xg serotonin could have been released
from these platelets. For the reasons discussed
above, the calculated number of platelets trapped in
lung may well be an underestimate. On the other
hand, not all dense granules were extruded from the
trapped platelets. Nevertheless, with these approxi-
mate amounts of histamine and serotonin in mind,
further studies were performed to determine
whether these agents could have caused DxSO4-
induced hypotension.
Effect of Histamine on the Arterial Pressure of
the Rabbit
A biphasic arterial pressure response following
bolus histamine injection (100-300 ng, intrave-
nously) was obtained, as has been described previ-
ously (Brimblecombe et al., 1974). An initial marked
hypertensive phase was followed within 30 seconds
of histamine injection by a more prolonged hypo-
tensive phase lasting about 4-5 minutes (data not
shown). As has also been reported (Carroll et al.,
1974), the initial hypertensive response could be
ro
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FIGURE 9. In each panel (top, middle, and lower) the blood pressure
response following intravenous injection of dextran sulfate (D) in
seven rabbits is plotted (9). In the top panel, the intravenous infusion
of serotonin (200 fig over 1 minute) is superimposed upon the DzSO,
response in the same animals. In the middle panel, the intravenous
infusion^ of histamine (100 fig over 1 minute) is superimposed upon
the DxSO4 response in the same animals. In the bottom panel, the
intravenous infusion of a mixture of serotonin and histamine (200 itg
and 100 ng, respectively, infused over 1 minute) is superimposed
upon the DxSOt response in the same animals. These data show that
the infusion of serotonin and histamine together more closely mim-
icked the blood pressure changes following DxSO, injection than the
infusion of either agent alone. Infusion of serotonin caused immediate
marked hypotension (together with bradycardia—not shown in Fig.
9), whereas infusion of histamine did not cause hypotension until
after the infusion had stopped.
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blocked by the Hi antagonist, chlorpheniramine (20
mg/kg) (data not shown), and the hypotensive re-
sponse could be blocked by the H2 antagonist, ci-
metidine (10 mg/kg) (data not shown). However,
this pattern of arterial pressure response following
bolus histamine injection bore no resemblance to
the DxSO4-induced hypotensive response. Infusion
of 50-200 jig histamine over a 1-minute period
instead of as a bolus caused mild hypertension or
no change in arterial pressure during the infusion.
When the infusion was stopped, mild hypotension
occurred (Fig. 9, middle panel). These arterial pres-
sure changes did not resemble the changes seen
after DXSO4 injection. Furthermore, in other studies,
infusion or injection into the right ventricle (to by-
pass the sinus node) also caused hypertension fol-
lowed by mild hypotension, as described above.
Thus it was not possible to reproduce the DxSO4-
induced hypotension and bradycardia by histamine
injection over a wide dose range, no matter how the
histamine was administered.
Effect of Serotonin upon the Systemic Arterial
Pressure of the Rabbit
Serotonin injection (22 /ig, intravenously) caused
immediate bradycardia and hypotension with a fall
in arterial pressure of about 30% (Fig. 10, panels B
and C). This pattern of hypotension and bradycardia
was very similar to that caused by DxSO4 injection.
This effect could be inhibited by prior injections of
cimetidine (60 mg/kg) (Fig. 10, panels D and E).
Intraarterial injection of serotonin (22 fig) repro-
ducibly produced only a small rise in arterial pres-
sure (Fig. 10, panel A). Furthermore, injection of
serotonin (200 ^ g) alone as a 1-minute infusion
immediately induced hypotension and bradycardia
similar to that seen after injection of DXSO4 (Fig. 9,
top panel), although the duration of the hypotension
was slightly less than that observed after DxSO4.
However, mixing serotonin (200 fig) together with
histamine (100 jig) produced a more prolonged hy-
potensive effect, which was almost identical to that
observed after DxSO4 injection (Fig. 9, bottom
panel). These findings implied that the major agent
responsible for hypotension and bradycardia follow-
ing DxSO4 injection was serotonin, although hista-
mine probably reduced the immediate hypotension
and enhanced the second phase of hypotension. We
therefore performed further studies to determine
whether serotonin could be the major agent respon-
sible for DxSO4-induced hypotension and bradycar-
dia.
Plasma Serotonin Concentration after DxSO4
Injection
Blood was removed from an intraarterial catheter
at 30-second intervals after DxS04 injection (Meth-
ods). The plasma was immediately separated and
frozen for serotonin assay (Methods). The results
are shown in Figure 11. Immediately after DxSO4
injection, the level of plasma serotonin rose 5-fold
Circulation Research/Vol. 57, No. 2, August 1985
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FIGURE 10. Effect of serotonin (S) injection (22 ng) on the cardiovas-
cular system of a rabbit. Intraarterial injection (panel A) caused a
small rise in arterial pressure (the downspike is an injection artifact
caused by injecting through the catheter used to monitor arterial
pressure). Intravenous injection of serotonin caused bradycardia and
hypotension (panel B) which was reproducible (panel Q. Cimetidine
(Q injection (60 mg/kg) intravenously had no effect on heart rate or
blood pressure (panel D), but it changed the cardiovascular effects
normally seen after intravenous injection of serotonin (hypotension
and bradycardia) to a small rise in pressure similar to that seen after
intraarterial injection (panel E).
and then returned rapidly to baseline values within
3 minutes. Injection of serotonin (22 /zg) doubled
the plasma serotonin concentration (Fig. 11). The
mean baseline serotonin concentration was 552 ±
51 ng/ml. From these data it can be estimated that
approximately 100-300 ^g of serotonin (equivalent
to the content of 3-9 X 109 platelets) were released
after DxSO4 injection (assuming a blood volume of
180 ml in a 2.5-kg rabbit). This is in good agreement
with the value of 217 ^g of serotonin potentially
released from trapped platelets in the lung (see
above).
Since the method used for measuring plasma se-
rotonin employed fluorescence of OPT in acidified
s o o .
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FIGURE 11. Plasma serotonin measured by fluorescence at 475 nm
(see Methods) increased nearly 5-fold in arterial blood 1 minute after
DxSO4 injection (n «• 5). Within 5 minutes, the excess serotonin had
disappeared from plasma. Injection of serotonin intravenously (22 ng,
the amount required to produce hypotension and bradycardia) caused
a doubling of the measured fluorescence at 475 nm.
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plasma, it was not entirely specific for serotonin. To
confinr. that serotonin had been released into
plasma after DXSO4 injection, we analyzed samples
(in the absence of OPT) by high pressure liquid
chromatography (see Methods). Under these condi-
tions, a peak of fluorescence at 210 run was observed
in plasma removed immediately after, but not be-
fore, DxSO4 injection. It corresponded exactly to the
peak observed when serotonin alone was analyzed
on the same system with respect to both peak size
and retention time (data not shown). These data
confirm that serotonin appeared in blood immedi-
ately after DxSO4 injections and that this assay was
quantitative.
Plasma Histamine Concentration after DxSO4
Injection
Blood was removed at intervals after DxSO4 in-jection, and the plasma was separated and assayed
for histamine, as described in Methods. The normal
histamine level in rabbit plasma was 8.1 ± 2.9 ng/
ml (n = 7). Within 0.5-1 minute after injection of
DxSO4 the level had risen 7-fold (Fig. 12). The
histamine level returned to normal within 5 minutes
of DxSO4 injection. Injection of histamine (100 /xg),
intravenously, in two rabbits yielded values of 333.6
and 342.3 ng/ml at 20 seconds and 6.5 and 24.0 ng/
ml at 60 seconds after histamine injection.
These results confirm that histamine was released
after DxSO4 injection. They emphasize how tran-
sient was the rise of measurable histamine in blood.
However, the amount of histamine required to pro-
duce hemodynamic effects of the magnitude seen
after DxSO4 injection, produced a peak of histamine
approximately 6-fold higher than that seen after
DxSO4 injection. This is in contrast to the results
with serotonin, described above (Fig. 11), where the
amount of serotonin required to produce hemody-
namic effects comparable to those seen after DxSO4
injection gave a peak amount of serotonin approxi-
mately 6-fold lower than that seen after DxSO4
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FIGURE 12. Plasma histamine measured by formation of pH-methyl]
histamine by histamine hi-methyltransferase (see Methods). The his-
tamine concentration in blood increased 7-fold within 1 minute after
DxSOt injection (n = 4). Within 5 minutes, the histamine concentra-
tion had returned to normal.
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FIGURE 13. Nine rabbits were pretreated with kelanserin (4 mg/kg,
intravenously, before injection of serotonin, histamine, and DxSOJ.
Those rabbits in which ketanserin inhibited the serotonin response
had a small hypotensive response to DxSO*. Those rabbits in which
ketanserin did not inhibit serotonin-induced hypotension had a large
response to DXSOA (r = 0.76, P = 0.02).
injection. These findings support the concept that
the major agent responsible for immediate hypoten-
sion following DxSO4 injection was serotonin, not
histamine.
Effect of Inhibitors on Serotonin and
DxSO4-Induced Hypotension
Ketanserin
The serotonin antagonist ketanserin was tested
for its ability to block the hemodynamic effects seen
after both DxSO4 and serotonin injection. The ca-
pacity of ketanserin to block serotonin-induced
hypotension was variable in different animals. How-
ever, in those animals in which ketanserin did in-
hibit serotonin-induced hypotensin, the DxSO4-in-
duced response also was prevented. In those animals
in which ketanserin did not inhibit serotonin-in-
duced hypotension, the DxS04 response was not
prevented (Fig. 13). No inhibition of the histamine
response by ketanserin was seen (data not shown).
These results are consistent with mediation of
DxSO4-induced hypotension by serotonin.
Methysergide
Methysergide, a serotonin antagonist, was also
tested as a potential tool for use in these studies.
However, methysergide infusion, even at high doses
(up to 20 mg/min), failed to prevent serotonin-
induced hypotension and bradycardia (data not
shown). Furthermore, histamine-induced hypoten-
sion was enhanced by methysergide infusion (data
not shown). Therefore, methysergide could not be
used as a serotonin antagonist for these studies.
dmetidine
Cimetidine also was tested as a specific histamine
H2 antagonist for use in these studies, and was used
at three doses. In each case, the hypotensive re-
sponse (measured as the mean arterial pressure) to
serotonin (22 ng) and histamine (100 fig) was com-
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pared before and after cimetidine injection and was
expressed as percent of the preinjection value. Fi-
nally, in each animal (n = 4), DxSO4 and cimetidine
were injected within a 10-minute period. At a ci-
metidine dose of 2 mg/kg, the serotonin-hypoten-
sive response was diminished from 47.5 ± 4.7% to
35.3 ± 7.1%, the histamine-hypotensive response
was diminished from 14.3 ± 6.3% to 8.5 ± 2.8%,
and the DxSO4 response was 32.5 ± 5.1% (compared
to 33.0 ± 2.5%, n = 7, for the control group shown
in Fig. 9). At a cimetidine dose of 12 mg/kg, the
serotonin response was diminished from 42.5 ±
3.2% to 20.5 ± 5.3%, P = 0.03, the histamine-
hypotensive response was diminished from 12.2 ±
5.0% to 3.0 ± 2.3%, P = 0.05, and the DxSO4
response was 21.5 ± 5.9% (compared with 33.0 ±
2.5%, n = 7, for the control group of rabbits shown
in Fig. 9). At high doses of cimetidine (60 mg/kg)/
the hypotensive response to serotonin injection was
completely inhibited in five rabbits, as has been
reported previously (Wiggins and Campbell, 1983),
and as illustrated in Figure 10. This dose of cimeti-
dine also largely prevented the DxSO4-induced hy-
potension (Fig. 14). From these studies, we conclude
that cimetidine in the rabbit inhibits serotonin-in-
duced hemodynamic changes even at moderate
doses (12 mg/kg). The effect of 2 mg/kg of cimeti-
dine was not statistically significant. However, at
this lower dose, which should have been sufficient
to inhibit H2 effects, the DxSO4 response was not
inhibited. At the intermediate dose of cimetidine (12
mg/kg)/ the DxSO4 response was somewhat de-
pressed in parallel with the serotonin response. This
result does not rigorously discriminate between se-
rotonin and histamine as the mediator of the re-
sponse, but is compatible with the concept that
serotonin is the major mediator, and strongly sup-
ports the concept that serotonin and/or histamine
caused the DxSCVinduced hypotension.
Role of Autonomic Nerves in Mediating
Serotonin-Induced Hypotension and Bradycardia
Serotonin has been shown to cause bradycardia
and hypotension in rabbits primarily via autonomic
Circulation Research/Vo/. 57, No. 2, August 1985
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FIGURE 14. Effect of cimetidine (60 mg/kg, intravenously) upon the
hemodynamic changes induced by DxSOt injection. Both immediate
hypotension and bradycardia were markedly inhibited by cimetidine
(n = 3 for both groups).
FIGURE 15. Serotonin injection (22 ng, intravenously) caused a 30%
fall in mean arterial pressure (MAP) beginning immediately after
injection (n = 3). Section of vagus and depressor nerves delayed and
diminished the serotonin-induced fall in MAP (P < 0.05 at 10 and 15
seconds after injection). In control animals, sham section resulted in
a fall in MAP that was similar to that seen in the experimental
animals prior to nerve section (n = 3).
reflexes (Erspamer, 1966). A study was therefore
performed to determine whether these reflexes were
responsible for DxSO4-induced hypotension. Both
the vagus and depressor nerves were identified in
the neck of rabbits (see Methods). In one group of
animals, the nerves were cut. hi the other group
(sham-operated), the nerves were left intact. The
response of these two groups of animals to intrave-
nous serotonin injection is shown in Figure 15.
Before section, both groups of animals showed a
similar hypotensive response to intravenous sero-
tonin (22 ng). After section, this hypotensive re-
sponse was both delayed and blunted. However, a
definite response still was present after nerve sec-
tion, which might have been caused by a reflex
initiated by receptors in the carotid sinus that was
left intact in this experiment. Thus, after serotonin
injection into a central vein, the time taken to reach
the carotid sinus would be longer, thus causing the
delayed response. (In other experiments, injection
of serotonin directly into the common carotid artery
reproducibly caused hypotension and bradycardia).
These two groups of rabbits were then injected
with DxSO4 (20 mg/kg). As shown in Figure 16, the
initial marked hypotensive response was prevented
by vagus and depressor nerve section. Delayed hy-
potension did occur 2-3 minutes after DxSO4 injec-
tion. We conclude that vagus and depressor nerve
section did partially prevent DxSO4-induced hypo-
tension. However, a further experiment was per-
formed to determine whether inhibition of the ca-
rotid sinus receptors, in addition to the heart and
lung receptors, would completely prevent DxSO4
induced hypotension.
Effect of Carotid Ligation Plus Vagus and
Depressor Nerve Section
Two groups of three rabbits were treated as in the
previous experiment, except that, in addition to va-
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FIGURE 16. Rabbits in which both vagus and depressor nerves were
sectioned showed partial inhibition of the response to intravenous
DxSO, compared with control (P < 0.05 at 45, 60, 75, 90, and 105
seconds) (n = 3 for both groups).
gus and depressor nerve section, the carotid arteries
on both sides were ligated (see Methods). Since the
baroreceptors were left intact, this procedure itself
caused an initial 30% rise in mean arterial pressure.
However, if the rabbits were left for 60 minutes
following the procedure, the systemic arterial pres-
sure fell to within 10% of precarotid ligation values
and was stable. Rabbits treated in this way showed
an immediate hypotensive response to serotonin
injected into the carotid artery above the point of
ligation, but they showed a markedly blunted re-
sponse to intravenous serotonin injection (Fig. 17).
However, the hypotensive response was not pre-
vented completely, and a small response was noted
in all animals. This may reflect the effects of other
accessible serotonin receptors not excluded by the
procedure (see Discussion). However, this maneuver
did largely prevent DxSO4-induced hypotension(Fig. 18). A further study was performed to confirm
that nerve section and carotid ligation did not
Carotid Ligation/
Nerve Section
Sham Operated
MINUTES
FIGURE 17. Effect of serotonin injection (arrow) upon mean arterial
pressure (MAP) in rabbits with both nerve section and bilateral carotid
ligation (n = 3) compared with control rabbits (n = 3). Although
serotonin-induced hypotension and bradycardia were not completely
inhibited, they were markedly diminished in the carotid-ligated/
nerve-sectioned animals.
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FIGURE 18. Injection of DxSOt intravenously caused almost no
hypotension or bradycardia in rabbits previously treated by section of
vagus and depressor nerves together with bilateral carotid ligation
(n = 3). Control rabbits exhibited the normal hypotensive response
together with bradycardia seen after intravenous DxSO4 injection
(n = 3).
prevent vasodilator responses nonspecifically. As
shown in Fig. 19, nerve section diminished the re-
sponse to serotonin as described above, but did not
reduce the response to bradykinin (1 ng) or sodium
nitroprusside (50 ^g)- Similarly, carotid ligation in
addition to nerve section markedly reduced the se-
rotonin response while leaving the response to bra-
dykinin and sodium nitroprusside intact. The values
for presection, post-nerve section, and post-nerve
section plus carotid ligation, were, for serotonin,
51.3 ± 14.8, 29.0 ± 3.2, and 14.3 ± 3.2%, for
bradykinin were 61.3 ± 10.3, 62.3 ± 10.2, and 57.0
± 12.7%, and for nitroprusside were 38.3 ± 13.2,
44.3 ± 9.7, and 47.3 ± 15.9%, respectively (n = 4).
From these studies on the effect of nerve section
and carotid ligation, we conclude that an intact
autonomic nervous system was necessary for the
hypotension and bradycardia observed following
DxSO4 injection.
Discussion
In the experiments described, an anaphylactoid
response was induced by intravenous injection into
rabbits of the polyanion dextran sulfate (DxSO4).
This 'anaphylactoid' response included the follow-
ing features: hypotension, bradycardia followed by
tachycardia, irregular respiration, wheezing, bowel
peristalsis with occasional defecation and micturi-
tion, and a bleeding tendency. The original purpose
of the experiment was to observe the consequences
of activation of Hageman factor in vivo by a sub-
stance known to activate the HF system, namely
dextran sulfate (Kluft, 1978; Ulevitch and Johnston,
1980). Hageman factor activation caused by DxSO4
injection would be expected to result in kinin gen-
eration with consequent hypotension (Cochrane and
Griffin, 1982). In fact, although the Hageman factor
system was activated in these experiments (as
judged by proteolysis of circulating radiolabeled rab-
bit Hageman factor, prekallikrein and high molecu-
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FIGURE 19. Intravenous injection of serotonin ("5-HT,' 22
fig), bradykinin ("BK," 3 fig) or sodium nitroprusside CNP,"
50 fig) into intact animal ("control"), animal with vagus
and depressor nerves cut ("nerve section"), or animal with
nerve section plus carotid ligation ("carotid occlusion").
Although the hypotensive response to serotonin was di-
minished by nerve section and markedly inhibited by
carotid ligation in addition to nerve section, the response
to bradykinin and sodium nitroprusside remained intact.
lar weight kininogen (data not shown), HF system
activation was not responsible for the observed
changes in systemic arterial pressure and heart rate.
This was demonstrated by finding that Hageman
factor depletion did not prevent the response, and
inhibition of kininase II (by SQ20881) did not en-
hance the hypotension. Therefore, a series of studies
was performed to determine the mediators involved
in DxSCVinduced hypotension.
Dextran sulfate has been reported to activate the
alternative pathway of complement (Burger et al.,
1975). In addition, in rabbits, cobra factor injection
has been reported to cause immediate hypotension
similar to that seen after injection of DxSO4 (Ulev-
itch and Cochrane, 1977). Furthermore, in the stud-
ies described here, DxSO4 injection caused a 10%
fall in antigenic C3 levels in blood, and this was
accompanied by blood neutropenia (Fig. 2) in asso-
ciation with neutrophil margination in lung capillar-
ies (Fig. 7). This sequence of events is well described
as a consequence of C5a production or injection in
vivo (Jacob, 1981). Further evidence that comple-
ment activation did indeed occur after DxSO4 injec-
tion is provided by the finding that, when rabbits
were depleted of C3 using cobra factor, neutropenia
was prevented, as was the characteristic rebound
neutrophilia that followed DxSO4 injection (Fig. 2).
However, in these same experiments, in spite of the
above evidence for complement activation, C3 de-
pletion did not prevent DxSO4-induced hypotension
and bradycardia (Fig. 3). A complement-independ-
ent mechanism must therefore have been responsi-
ble.
Platelet depletion has been shown to prevent the
hypotension caused by IgE-induced anaphylaxis in
the rabbit (Benveniste et al., 1972; Pinckard et al.,
1977; McManus et al., 1979). In the studies de-
scribed here, platelet depletion similarly prevented
DxSO4-induced hypotension and bradycardia (Fig.
6). Furthermore, following DxSO4 injection, platelets
were shown to disappear from blood (Fig. 2) and
appear in lung (Table 1), where ultrastructural stud-
ies 2 minutes after DxSO4 injection showed them to
be aggregated and in the process of degranulating
(Figs. 7 and 8).
But how might platelet activation in the lung cause
hypotension? Rabbit platelets contain both hista-
mine and serotonin in their dense granules (Da
Prada et al., 1981). The fact that cimetidine infusion
at high doses prevented DxSO4-induced hypoten-
sion pointed toward histamine as the important
mediator. However, when histamine itself was in-
fused or injected intravenously, or into the right
ventricle, the predominant result was either no
change in blood pressure or immediate hypertension
with tachycardia followed by a mild hypotensive
phase (Fig. 9), as has been previously described in
the rabbit (Brimblecombe et al., 1974; Carroll et al.,
1974). It therefore was not possible to account for
the DxSO4-induced hypotension and bradycardia
simply in terms of histamine release from platelets
(or from the basophils which disappeared from the
blood and appeared in degranulated form in the
lung following DxSO4 injection). In contrast, sero-
tonin injection reproduced the immediate hypoten-
sion and bradycardia seen following DxSO4 injec-
tion (Fig. 10), although the hypotension was less
prolonged than that seen after DxSO4 injection, even
when high doses of serotonin were injected (300
^g). That histamine did probably contribute to the
DxSO4-induced hemodynamic changes was sug-
gested by the finding that a combination of hista-
mine (100 Mg) and serotonin (200 fig) infused over
1 minute appeared to reproduce more closely both
the extent and duration of the events seen after
DxSO4 injection (Fig. 9).
In quantitative terms, enough platelets accumu-
lated in lung following DxSO4 injection to release
about 100 j*g of histamine and 200 ng of serotonin.
Direct measurement of serotonin in blood following
DxSO4 injection confirmed that 5-10 times more
serotonin could be detected after DxSO4 injection
than was detected after intravenous injection of 22
fig serotonin (sufficient to cause hypotension and
bradycardia). In contrast, direct measurement of his-
tamine in blood following DxSO4 injection showed
that 5-10 times less histamine could be detected
after DxSO4 injection than was detected after injec-
tion of 100 Mg of histamine (sufficient to cause only
mild hypotension). These independent measure-
ments confirmed that the amount of serotonin re-
leased was adequate to cause the observed hypoten-
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sion and bradycardia. In contrast, the amount of
histamine measured in blood probably was insuffi-
cient to cause the observed hemodynamic effects.
Ketanserin, a serotonin antagonist, did inhibit the
DxSO4-induced hypotension, but only in those rab-
bits in which it inhibited the serotonin-induced
response. These findings are compatible with the
concept that the major cause of DxSO4-induced
hypotension was serotonin. This effect of a specific
serotonin antagonist in preventing dextran-induced
hypotension is similar to that reported in rats by
Berstad (1981). However, the effect of serotonin
antagonists, such as ketanserin, might occur by in-
hibiting platelet aggregation in blood vessels rather
than by inhibiting the effect of released serotonin
on tissue receptors. This concept recently has been
emphasized by Meuleman et al. (1983) and Bergqvist
et al. (1983).
The finding that cimetidine inhibited DxSO4-in-
duced hypotension initially pointed toward hista-
mine as the important mediator. However, at the
doses used, cimetidine also prevented the serotonin-
induced cardiovascular changes (Fig. 10), as has
been reported elsewhere (Wiggins and Campbell,
1983). This inhibition of hypotension by cimetidine
therefore did not discriminate between histamine
and serotonin in these experiments, although it did
support the concept that serotonin and/or histamine
was the mediator.
Further evidence that serotin was the major factor
operative in causing DxSO4-induced hypotension
was the finding that DxSO4-induced hypotension
could be diminished by section of the vagus and
depressor nerves, and could be prevented by carotid
ligation in addition to nerve section. That this was
not a nonspecific response to this maneuver was
shown by demonstrating that the responses to bra-
dykinin and sodium nitroprusside remained intact
while the response to serotonin was lost. This again
supported the concept that serotonin-mediated
autonomic reflexes were largely responsible for the
observed hemodynamic changes. Taken together,
these results all point toward a serotonin-mediated
chemoreflex as the major cause of DxSO4-induced
hypotension. Histamine release undoubtedly oc-
curred after DxSO4 injection, and certainly contrib-
uted to the prolongation of hypotension. However,
it was not the major factor.
The chemoreflexes by which serotonin induces
hypotension and bradycardia were originally iden-
tified by Bezold and Hirt in 1867 and were further
analyzed by Jarish and Richter (1939) using vera-
trum alkaloids. Dawson and Comroe (1954) defined
three separate chemoreflexes in the heart and lungs.
These were (1) a coronary chemoreflex, (2) a pul-
monary depressor chemoreflex, and (3) a pulmonary
respiratory chemoreflex. The afferent limb of these
reflexes begins with chemoreceptors in the lungs,
heart, carotid sinus, and probably also the nodose
ganglion (Jacobs and Comroe, 1971). Signals travel
in the vagus nerve, and depressor nerve in the rabbit
(Winton and Bayliss, 1955), to the autonomic nerve
centers in the brain. The efferent limb appears to
take the form of a general increase in vagal tone and
a decrease in sympathetic tone, but there are also
more localized organ effects (e.g., on lungs or car-
diovascular system) depending upon the site of re-
ceptor stimulation (Erspamer, 1966). The results of
this change in autonomic climate almost certainly
affect every organ. In this study, heart rate and
blood pressure were measured. Both decreased
markedly. Similar responses to serotonin injection
in rabbits and cats have previously been docu-
mented (Erspamer, 1966). In other studies, reflex
vasodilation due to decreased sympathetic activity
has been observed in the isolated hind limb, liver,
kidney, intestine, spleen, and retina (Erspamer,
1966). A recent review by Mecca and Webb (1984)
suggests that the vasodilator response to serotonin
may be the result of a combination of neural and
direct vascular events. However, the results from
this study suggest that the neural events predomi-
nate, at least with respect to systemic blood pressure
changes induced by intravenous injection of sero-
tonin in the rabbit.
Increased parasympathetic activity can cause
smooth muscle contraction in the gut, bladder, and
in bronchioles, and might well have accounted for
or contributed to the noncardiovascular changes
observed in rabbits following DxSO4 injection(wheezing, micturition, defecation), although ana-
phylatoxins (C3a, C5a), together with histamine re-
lease, bradykinin generation, or direct effects of
serotonin, might also have contributed to these
events. It is possible that the observed irregular
respiration was also due to the chemoreflex, since
this is a regular feature of the serotonin-induced
reflex (Erspamer, 1966).
The mechanism by which DxSO4 caused platelet
activation in the lung has not been worked out,
although DxSO4 has previously been observed to
cause platelet aggregation (Walton, 1953; Brossmer
and Pfleiderer, 1966; Tiffany and Penner, 1981). In
preliminary studies, [3H]serotonin was not released
from platelet-rich plasma; neither was it released
from washed plasma-free platelets when incubated
in the presence of DxSO4. These findings imply that
some mechanism other than a direct interaction
between DxSO4 and platelets was taking place. We
observed that blood basophil counts diminished im-
mediately after DxSO4 injection, and that cells which
were probably degranulated basophils appeared in
lung at the same time. It is therefore possible that
DxSO4 injection resulted in basophil activation with
consequent release of platelet-activating factor
(AGEPC). If so, the sequence of events would be
similar, but not as profound, as those observed to
occur in the model of IgE anaphylaxis in the rabbit
(Benveniste et al., 1972; Pinckard et al., 1977;
McManus et al., 1979). No evidence is provided to
show that DxSO4 does interact directly with baso-
phils, although such an interaction might occur
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either via a charge effect or, as has recently been
suggested, by a simple osmotic effect (Findlay et al.,
1981). An alternative explanation is that rabbits
could have natural antibodies against dexrrans (Pa-
losvo and Milgrom, 1981), or that DxSO4-immuno-
globulin interactions might trigger platelet activation
(Levy et al., 1981). Activation of complement by
DxSQi may also have contributed to platelet acti-
vation and thrombocytopenia as well as neutropenia
(Ulevitch and Cochrane, 1977). However, this
mechanism cannot totally account for the platelet-
induced hypotension, since C3 depletion did not
prevent DxSO.»-induced hypotension.
Dextran sulfates have been studied as synthetic
heparin-like molecules (Walton, 1954), and the se-
vere bleeding tendency induced by DxSO« in these
studies probably was due to this heparin-like effect.
As has been emphasized by this discussion,
DxSC>4 injection results in activation of many me-
diator systems. The question addressed in this study
was which system caused the observed cardiovas-
cular changes? Evidence is provided that platelet
activation in the lungs caused bradycardia and hy-
potension by means of powerful autonomic reflexes
activated by serotonin as outlined below.
Platelet-activating substances
I
Platelet activation in heart/lungs
I
Serotonin
I
Receptors in heart/lungs/carotid
I
Autonomic nerve centers
I
| Cholinergic drive
I Sympathetic drive
I
Effects on organs
(Blood flow, smooth muscle,
heart rate, etc.)
We would like to acknowledge help with these studies: support
from Dr. Charles Cochrane, Research Institute of Scnpps Clinic, La
jolla, California; assistance with the HPLC analysis from Dr. S.H.
Phan, Department of Pathology, University of Michigan Medical
School, Ann Arbor, Michigan; histamine measurement in rabbit
plasma from Dr. Ken Mathews and Polly Pan (Department of Internal
Medicine, University of Michigan, Ann Arbor); art work performed
by M. Marshall; and the secretarial assistance of Catherine Corson
and Elizabeth Reid. We are grateful to Drs. Peter Ward and Richard
Tannen for reading the manuscript and making helpful comments.
This work was supported in part by U.S. Public Health Service
Grant AM30673 from the National Institute of Arthritis, Diabetes,
Digestive and Kidney Diseases and a grant-in-aid from the American
Heart Association and the Michigan branch of the American Heart
Association. Roger Wiggins is an Established Investigator of the
American Heart Association.
Drs. Wiggins, Glatfelter and Kunkel are affiliated with the Uni-
versity of Michigan Medical School, and Drs. Campbell and Ulevitch
are affiliated with Scripps Clinic.
Circulation Research/Vol. 57, No. 2, August 1985
Address for reprints: Roger C Wiggins, M.D., Internal Medicine
(Nephrology), The University of Michigan, 3238 South Ambulatory
Care Building, Ann Arbor, Michigan 48109.
Received November 2, 1983; received in revised form November
3, 1984; accepted for publication April 11, 1985
References
Benveniste J, Henson PM, Cochrane CA (1972) Leukocyte-de-
pendent histamine release from rabbit platelets. The role of
IgE, basophils and a platelet activating factor. J Exp Med 136:
1356-1377
BeTgvist D, Arvidsson S, Esquirel CO, Lindblad B, Haglund U
(1983) The effect of serotonin inhibition on initial microvessel
hemostasis and platelet aggregation in vivo. Thromb Haemost
49: 173-175
Bezold A von, Hirt L (1867) Unters physiol Lab Wurzburg 1: 73
Bouma BN, Griffin JH (1977) Human blood coagulation Factor
XI. Purification, properties, and mechanisms of activation by
activated factor XII. J Biol Chem 252: 6432-6437
Brimblecombe RW, Owen D, Parsons M (1974) The cardiovas-
cular effects of histamine in laboratory animals. Agents Actions
4: 191-192
Brossmer R, Pfleiderer T (1966) Zum mechanismus der throm-
bozytaggregahon. Naturwissenschaften 18: 464-466
Burger RV, Hadding U, Schlorlemmer H, Brade V, Bitter-Sver-
mann, D (1975) Dextran sulfate: A synthetic activator of C3
via the alternative pathway. I. Influence of molecular size and
degree of sulfation on the activation potency. Immunology 29:
249-254
Carroll P, Glover W, Cart, N (1974) Cardiovascular histamine
receptors in the rabbit. Aust J Exp Biol Med Sci 52: 577-582
Cochrane CG, Griffin JH (1982) The biochemistry and patho-
physiology of the contract system of plasma. In Advances in
Immunology, edited by HG Kunkel, FT Dixon. New York,
Academic Press, pp 242-297
Da Prada M, Richards JG, Kettler R, (1981) Amine storage organ-
elles in platelets. In Platelets in Biology and Pathology, edited
by J Gordon. Amsterdam, Elsevier North Holland Biomedical
Press pp 107-144
Dawson GS, Comroe, JH (1954) Chemoreflexes from the heart
and lungs. Physiol Rev 34: 167-201
Dyer J, Warren K, Merlin S, Metcalfe DD, Kalliner M (1982)
Measurement of plasma histamine: Description of an improved
method and normal values. J Allergy Clin Immunol 70: 82-87
Erspamer V (1966) Peripheral physiological and pharmacological
actions of indole alkylamines. In Handbook of Experimental
Pharmacology, vol XIX, 5-Hydroxytryptamine and Related In-
dole Alkylamines, edited by V ErspameT. New York, Springer-
Verlag, pp 245-351
Findlay SR, Dvorak AM, Kagen-Sobokka A, Lichtenstein LM
(1981) Hyperosmolar triggering of histamine release from hu-
man basophils. J Clin Invest 67: 1604-1613
Griffin J, Cochrane CA (1976) Human Factor XII. Methods En-
zymol 45: 56-65
Humphrey JH, Toh CC (1954) Absorption of serotonin (5-hy-
droxytryptamine) and histamine by dog platelets. J Physiol
(Lond) 124: 300-304
Jacob H (1981) The role of activated complement and granulo-
cytes in shock states and myocardial infarction. J Lab Clin Med
98: 645-653
Jacobs L, Comroe JH (1971) Reflex apnoea, bradycardia and
hypotension produced by serotonin and phenyldiguanide act-
ing on the nodose ganglion of the cat. Ore Res 29: 145-155
Jarisch A, Richter H (1939) Arch Exp Pathol Pharmakol 193: 347-
555
Kluft C (1978) Determination of prekallikrein in human plasma:
Optimal conditions for activating prekallikrein. J Lab Clin Med
91: 83-95
Kremer M, Wright S, Scarf RW (1933) Experimental hypertension
and the arterial lesions in the rabbit. Br J Exp Pathol 14: 281-
290
Levy DE, Homer AA, Solomon A (1981) Immunoglobulin-sul-
fated polysaccharide interactions. J Exp Med 153: 883-896
Marangos PJ, Campbell IC, Schmechel DE, Murphy DL, Goodwin
D
ow
nloaded from
 http://ahajournals.org by on March 6, 2019
Wiggins et al. /Platelet Serotonin-Induced Autonomic Reflexes
FK (1980) Blood platelets contain a neuron-specific enolase
subunit. J NeuTOchem 34: 1254-1258
McManus LM, Hanahan DJ, Demopoulos CA, Pinckard RN
(1979) Pathobiology of the intravenous infusion of acetyl
glyceryl ether phosphorylcholine (AGEPC), a synthetic plate-
let-activating factor (PAF), in the rabbit. J Immunol 124: 2919-
2924
Mecca TE, Webb RC (1983) Serotonin and vasodilation. In Vaso-
dilator mechanisms, edited by PM Van Houtte, SF Vatner. New
York, S. Karger, pp 81-90
Meng AL, Pinckard RN, Halonen M (1973) Ontogeny of the
release and reactivity to the mediators of IgE-induced acute
allergic reactions in the rabbit: The homologous PCA reaction.
J Immunol 110: 1554-1561
Meuleman TR, Hill DC, Port JD, Stanley, TH, Pace NL, Moham-
mad SF (1983) Ketanserin prevents platelet aggregation and
endotoxin-induced pulmonary vasoconstriction. Crit Care Med
11: 606-611
Palosvo T, Milgrom F, (1981) Appearance of dextrans and anti-
dextran antibodies in human sera. Int Arch Allergy Appl Im-
munol 65: 153-161
Parbtani A, Cameron JS (1979) Platelet and plasma serotonin
concentrations in glomerulonephritis I. Thromb Res 15: 109-
125
Pinckard RN, Halonen M, Palmer JD, Bubler C, Shaw JO, Henson
PM (1977) Inrravascular aggregation and pulmonary sequestra-
tion of platelets during IgE-induced systemic anaphylaxis in
the rabbit. Abrogation of lethal anaphylactic shock by platelet
depletion. J Immunol 119: 2185-2193
Rand M, Reid G (1951) Source of serotonin in serum. Nature
277
(Lond) 168: 385
Tiffany ML, Penner JA (1981) Heparin and other sulfated poly-
anions and their interaction with the blood platelet. Ann NY
Acad Sci 37<h 662-667
Ulevitch RJ, Johnston AR (1980) In vitro studies of prekallikrein
activation in rabbit blood: The participation of red blood cells.
) Immunol 124: 2027-2033
Ulevitch RJ, Cochrane CG (1977) Complement-dependent hemo-
dynamic and hematologic changes in the rabbit. Inflammation
2: 199-216
Walton K (1953) Observations on the effects of a series of dextran
sulphates of varying molecular weight on the formed elements
of the blood in vitro. Br J Pharmacol 8: 340-347
Walton KW (1954) Investigation of the toxicity of a series of
dextran sulfate of varying molecular weight. Br J Pharmacol 9:
1-14
White JG (1974) Electron microscopic studies of platelet secretion.
In Progress in Hemostasis and Thrombosis, edited by TH Spaer.
New York, Grune & Srratton, pp 49-98
Wiggins RC, Campbell AM (1983) Inhibition of serotonin-me-
diated cardiovascular reflexes by cimeridine in the rabbit. Gen-
eral Pharmacol 14: 469-470
Wiggins RC, Cochrane CA, Griffin JH (1979) Rabbit coagulation
factor XI Purification and characterization. Thromb Res 15:
475-486
Winton FR, Bayliss LE (1955) Human Physiology. London, J.A.
Churchill Ltd, p 61
INDEX TERMS: Serotonin • Platelet • Chemoreflex • Hypoten-
sion
D
ow
nloaded from
 http://ahajournals.org by on March 6, 2019
